Lataa...
Splicing variants of androgen receptor in prostate cancer
Significant advances in our understanding of continued androgen receptor (AR) signaling in castration-resistant prostate cancer have led to the development and FDA approval of two next-generation androgen-directed therapies, abiraterone and enzalutamide. These new therapies heralded a new era of pro...
Tallennettuna:
| Julkaisussa: | Am J Clin Exp Urol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
e-Century Publishing Corporation
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4219285/ https://ncbi.nlm.nih.gov/pubmed/25374896 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|